FDA DEVICE FACTS
Capiflo 5001
K&L Distributing, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Capiflo 5001 Deep Vein Thrombosis Prevention Therapy System is intended to be an easy to use portable system, prescribed by a physician, and used to help prevent the onset of Deep Vein Thrombosis (DVT) in patients by stimulating blood flow in the extremities (through the stimulation of muscle contractions).
This device can be used in the home or clinical setting to:
- Assist and aid in the prevention of Deep Vein Thrombosis (DVT).
- Asa prophylaxis for Deep Vein Thrombosis (DVT) by persons expecting to be stationary for long periods of time.
- To increase blood circulation in the lower limbs.
- Help reduce postoperative swelling and pain.
- Cut down on wound healing time.
- Capiflo can assist in the treatment of:
- Chronic venous insufficiency
- The reduction of edema in lower limbs
- Venous stasis ulcers
- Arterial leg ulcers
- Diabetic leg ulcers
- Stasis dermatitis
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。